U.S. Markets close in 3 hrs 6 mins

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
9.99+0.06 (+0.65%)
As of 12:54PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.31
52-Week Change 39.24%
S&P500 52-Week Change 3N/A
52 Week High 314.10
52 Week Low 37.91
50-Day Moving Average 39.95
200-Day Moving Average 310.54

Share Statistics

Avg Vol (3 month) 32.25M
Avg Vol (10 day) 32M
Shares Outstanding 5159.98M
Float 141.74M
% Held by Insiders 13.20%
% Held by Institutions 1114.72%
Shares Short (Jul 30, 2020) 423.73M
Short Ratio (Jul 30, 2020) 412.21
Short % of Float (Jul 30, 2020) 423.19%
Short % of Shares Outstanding (Jul 30, 2020) 414.83%
Shares Short (prior month Jun 29, 2020) 426.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21194:1000
Last Split Date 3Apr 01, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 22.74%
Operating Margin (ttm)38.33%

Management Effectiveness

Return on Assets (ttm)26.94%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)426.84M
Revenue Per Share (ttm)2.71
Quarterly Revenue Growth (yoy)-12.50%
Gross Profit (ttm)293.02M
EBITDA 168.98M
Net Income Avi to Common (ttm)97.06M
Diluted EPS (ttm)0.62
Quarterly Earnings Growth (yoy)105.20%

Balance Sheet

Total Cash (mrq)253.25M
Total Cash Per Share (mrq)1.58
Total Debt (mrq)442.74M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.02
Book Value Per Share (mrq)-0.23

Cash Flow Statement

Operating Cash Flow (ttm)126.04M
Levered Free Cash Flow (ttm)79.44M